Loading...

Biofrontera Inc.

BFRIW•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.20
$0.10(105.87%)

Biofrontera Inc. (BFRIW) Stock Overview

Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 59.3/100

Key Financials

Market Cap21.9M
P/E Ratio-0.82
EPS (TTM)$-1.30
ROE-2.16%
Fundamental Analysis

AI Price Forecasts

1 Week$0.11
1 Month$0.08
3 Months$0.01
1 Year Target$0.01

BFRIW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biofrontera Inc. (BFRIW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 72.62, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.82 and a market capitalization of 21.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;